Pinsent Masons advises Bryan, Garnier & Co on Heidelberg Pharma AG’s capital increase
28 Jun 2021 | 02:23 pm |
Multinational law firm Pinsent Masons has advised Bryan, Garnier & Co on the successful EUR 20m capital increase of Heidelberg Pharma AG.
The transaction increased German based biopharmaceutical company Heidelberg Pharma AG’s share capital by approximately 10%, with the 3,106,637 newly issued shares offered to qualified institutional investors in Europe and the United States in an accelerated book-building process. At a subscription price of EUR 6.44 per share, the company raised gross proceeds of EUR 20 million.
The new shares were admitted to trading on the Frankfurt Stock Exchange on June 21, 2021.
Pinsent Masons advised Bryan, Garnier & Co, the sole global coordinator and sole bookrunner for the transaction. Bryan, Garnier & Co is one of the most active investment banks in the European growth sector, with a particular focus on healthcare, technology, consumer goods and business services. They are a fully registered broker-dealer, licensed and supervised by the FCA in Europe and FINRA in the US.
The Pinsent Masons team was led by Dr Susanne Lenz, LL.M. and included Roberta Markovina (Partner, London), Dušan Stojković (Senior Associate, Frankfurt) and Sara Šepac (Associate, Frankfurt).
Commenting on the transaction, Dr Susanne Lenz said:
"We are pleased to have worked with Bryan Garnier on this exciting and important transaction. With Heidelberg Pharma AG’s expertise in oncology, we are proud to have been part of the successful financing of a company on the cutting edge of biopharmaceutical research and development in Germany."
Latest press releases
Show me all press releasesPinsent Masons wins at FT Innovative Lawyers Europe 2026
Multinational law firm Pinsent Masons has been named the eighth most innovative European law firm at this year’s FT Innovative Lawyers Europe Awards. The firm also won in the Innovative Lawyers in Sustainability category.
Pinsent Masons advises SERT on transformational internalisation
Multinational law firm Pinsent Masons has advised Stoneweg Europe Stapled Trust (SERT) on its proposed aggregate c.€122 million acquisition of Stoneweg's pan-European investment management platform, a transformational transaction that will establish SERT as a fully integrated real estate owner, operator and investment manager with approximately €3.2 billion of assets under management.
Pinsent Masons advises Ghelamco on a €285m transaction in the Polish office market
Multinational law firm Pinsent Masons has advised developer Ghelamco on the €285 million sale of The Bridge, a landmark Warsaw office tower.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises FTI Consulting on sale of CX Lavender key client business to Omnicom Oceania
Multinational law firm Pinsent Masons has advised FTI Consulting, in its capacity as administrators of the CX Lavender group, on the sale of the company's key client-related business and associated workforce to Omnicom Oceania via its subsidiary, Clemenger BBDO Pty Ltd. The transaction completed in Q2 2026.
Pinsent Masons MPillay appoints finance partner in Singapore
Pinsent Masons MPillay has expanded its financing capability in Singapore and the Asia Pacific region with the appointment of Jessica Loy as a partner.
Pinsent Masons strengthens its competition law practice with the appointment of Christian Peeters
Multinational law firm Pinsent Masons is strengthening its Antitrust, Competition & Trade practice at its Dusseldorf/Germany office with the appointment of Christian Peeters, LL.M., effective 1 July 2026.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]